Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $8.1200 (2.4%) ($7.9500 - $8.1200) on Thu. Mar. 23, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.29% (three month average) | RSI | 32 | Latest Price | $8.1200(2.4%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.1% a day on average for past five trading days. | Weekly Trend | BCRX declines -3.1% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) ARKG(30%) XLRE(24%) CEMB(20%) IFRA(20%) SDY(20%) | Factors Impacting BCRX price | BCRX will decline at least -1.645% in a week (0% probabilities). VXX(-15%) VIXM(-13%) TLT(-10%) PCY(-8%) UUP(-7%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.645% (StdDev 3.29%) | Hourly BBV | -1.5 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-0.97(-111.95%) | Resistance Level | $8.46 | 5 Day Moving Average | $8.08(0.5%) | 10 Day Moving Average | $8.19(-0.85%) | 20 Day Moving Average | $8.46(-4.02%) | To recent high | -31.4% | To recent low | 2.4% | Market Cap | $1.433b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |